Galmed Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 257.7%.

Top 24 shareholders own 13.47% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
4.48%	Heights Capital Management, Inc.	269,238	US$95.4k	0%	0.06%
3.79%	G. Yarom Medical Research Ltd	227,790	US$80.7k	0%	no data
1.92%	Walleye Capital LLC	115,400	US$40.9k	-53.8%	no data
1.37%	Morgan Stanley, Investment Banking and Brokerage Investments	82,468	US$29.2k	312%	no data
0.74%	Two Sigma Advisers, LP	44,433	US$15.7k	-12.2%	no data
0.39%	Two Sigma Investments, LP	23,516	US$8.3k	-23.5%	no data
0.34%	Macquarie Investment Management Business Trust	20,400	US$7.2k	0%	no data
0.19%	Citadel Advisors LLC	11,251	US$4.0k	-72.2%	no data
0.12%	BBVA Asset Management, S.A., S.G.I.I.C	7,267	US$2.6k	0%	no data
0.046%	Tushia Consulting Engineers Ltd	2,762	US$978.6	-0.04%	no data
0.03%	Geode Capital Management, LLC	1,821	US$645.2	0.44%	no data
0.0083%	Shmuel Nir	500	US$177.2	0%	no data
0.0083%	Blackstone Alternative Investment Advisors LLC	500	US$177.2	0%	no data
0.0083%	David Sidransky	500	US$177.2	0%	no data
0.0062%	Yohai Stenzler	375	US$132.9	0%	no data
0.0062%	Guy Nehemya	375	US$132.9	0%	no data
0.0034%	Wells Fargo & Company, Securities and Brokerage Investments	204	US$72.2	0%	no data
0.0033%	TSFG, LLC	200	US$70.9	0%	no data
0.0033%	Doron Cohen	200	US$70.9	0%	no data
0.00088%	Osaic Wealth, Inc. , Asset Management Arm	53	US$18.7	0%	no data
0.00057%	Bourgeon Capital Management, LLC	34	US$12.1	0%	no data
0.00028%	Allworth Financial, L.P.	17	US$6.0	0%	no data
0.00012%	ZRC Wealth Management, LLC	7	US$2.6	0%	no data
0.00002%	Merrill Lynch & Co. Inc., Banking Investments	1	US$0.4	0%	no data